The largest database of trusted experimental protocols

Cpt 11

Manufactured by Pfizer
Sourced in Australia

CPT-11 is a laboratory product used for research purposes. It is a chemical compound that functions as a topoisomerase I inhibitor. The core function of CPT-11 is to inhibit the activity of topoisomerase I, an enzyme involved in the regulation of DNA topology.

Automatically generated - may contain errors

4 protocols using cpt 11

1

Purification of LZ-8 from Ganoderma lucidum

Check if the same lab product or an alternative is used in the 5 most similar protocols
CPT-11 (Irinotecan) was purchased from the Pfizer Pty Limited (Perth, Australia). LZ-8 was isolated from LZDCH (Yeastern Biotech, Taipei, Taiwan), which was extracted form Ganoderma lucidum, as described previously [24 (link), 25 (link)]. Briefly, LZDCH was dissolved and centrifuged, and proteins were obtained by filtration. LZ-8 was purified by fast protein liquid chromatography (GE Healthcare, Chicago, IL, USA).
+ Open protocol
+ Expand
2

Establishment of Colon Carcinoma Model in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animal use was approved by the Animal Care and Use Committee of the University of Alberta and conducted in accordance with Guidelines of the Canadian Council on Animal Care (AC08153). Female Fisher 344 rats (150–180 g of body weight and 11–12 weeks of age) were obtained from Charles River (QC, Canada). The use of female animals avoided potential confounding effects of sex, and allowed direct comparison with prior work in the same tumor model [13] (link), [14] (link). Rats were housed 2 per cage in a temperature (22°C) and light controlled (12 h light) room; water and food were available ad libitum. One week before chemotherapy, rats were separated into individual cages. The Ward colon carcinoma was provided by Dr. Y Rustum, Roswell Park Institute. Tumor pieces (0.05 g) were transplanted subcutaneously on the flank of the rats via trocar under slight isoflurane anesthesia. CPT-11 was provided by Pfizer as a ready-to-use clinical formulation. Atropine (0.6 mg/ml) was a clinical injectable formulation. Rats were killed by CO2 asphyxiation.
+ Open protocol
+ Expand
3

Synthesis and Procurement of Anticancer Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
TAK-931 was synthesized by Takeda Pharmaceutical Company Ltd. (23 (link)). Niraparib was purchased from Selleck China (Shanghai, China). Gemcitabine was purchased from Eli Lilly and Company (Indianapolis, IN, USA). CPT-11 (irinotecan hydrochloride injection) was purchased from Pfizer (Perth) Pty Limited (Bentley, WA, Australia). 5-FU (fluorouracil injection; 25 mg/ml) was purchased from Shanghai Xudong Haipu Pharmaceutical Inc. (Shanghai, China).
+ Open protocol
+ Expand
4

Cell Migration and Invasion Assays with Anticancer Drugs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell migration assay was performed in 24-well CIM plates (BD Biosciences, CA, USA). Briefly, 1–3 × 104 cells per well were seeded in serum-free medium plus indicated drugs in the upper compartment of the CIM plates. Serum-complemented medium was added to the lower compartment of the chamber. After 24 h incubation, cells that passed through the septum were fixed with cold methanol and stained with crystal violet. The average number of migrated cells in four random microscopic fields was counted. Cell invasion assay was performed in 24-well CIM plates coated with matrigel. Other steps were identical to those of cell migration assay. VP-16 was provided by Hengrui Medicine (Jiangsu, China), ADM and CPT-11 were provided by Pfizer (New York, NY, USA). Fludarabine (HY-B0069), Bay11–7082 (HY-13453), C-176 (HY-112906), KU55933 (HY-12016) and AG490 (HY-12000) were purchased from MCE (Middlesex County, NJ, USA). GSH was purchased from Beyotime (Beijing, China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!